It has been found that YC-1 effectively inhibits the migration of HCC cells through decreasing HIF-1 levels and the expression of downstream target genes, which implies that YC-1 has potential as a multipurpose anticancer drug and is worthwhile to develop for the prevention of tumor spreading [94]. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.